Sepsis Pathophysiological & Organisational Timing

NCT ID: NCT01099813

Last Updated: 2014-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15602 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-11-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project proposes to measure delay to admission to Intensive Care (ICU). Delays in the United Kingdom NHS are widely reported possibly because there are fewer ICU beds than in many other developed health care systems. Patients are inevitably admitted with more severe illness. Scores measuring this severity are used for research and benchmarking. However, although patients deteriorate over time, severity is probably neither directly nor linearly related to the duration of illness. Instead it is likely that the characteristics of severity change with time. In sepsis there is good biological evidence of this so that there is an early pro-inflammatory stage followed by later changes in metabolic, neuroendocrine, and immune systems. In addition to examining the effect of duration of illness prior to ICU admission, the investigators will also therefore investigate how severity changes over time.

SPOT(Light) is a prospective observational study. Treatment is not modified in anyway. Patients evaluated on the ward by critical care outreach teams, and subsequently admitted to critical care will be eligible. Severity of illness at the time of initial evaluation and eventual admission will be compared, and the effect of the duration of illness on 90 day survival investigated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is useful to consider time in critical illness from two perspectives. The first of these begins logically with onset of the pathology. With the exception of conditions such as myocardial infarction or trauma where this moment is marked by a classic symptom or an external event, then defining time zero is difficult. For this reason, an organisational frame of reference, such as hospital admission or time of referral to specialist team, is more commonly used. Delay following this organisational time is important because it is often a modifiable factor with regard to the delivery of health care. However, pathophysiological timing remains relevant because if the disease process is dynamic (and this is part of the hypothesis of this study) then it determines the phenotype of disease at any particular moment.

This project proposes to measure delay to admission to Intensive Care (ICU) using both organisational and pathophysiological timing. Delays in the United Kingdom NHS are widely reported {McQuillan:1998p127, Hillman:2001p90} possibly because there are fewer ICU beds than in many other developed health care systems.{Wunsch:2008p121} We intend to measure the chronological time between the moment when a patient is 'referred and assessed as requiring Critical Care', and their actual time of admission. We will determine how often delays occur, and whether they affect outcome. Requirements for critical care are not, however, absolute. Importantly, the assessment of a prospective patient is not made in isolation. If ICU beds are already fully occupied, then decision makers must organise a transfer to another unit (with risks to the patient), organise a premature discharge of another patient, or defer admission. We will also therefore consider such deferments alongside delays, and their impact on survival.

In addition, the project will consider pathophysiological timing. This is of particular importance in sepsis where current biological models suggest that there is a phased response to infection.{Riedemann:2003p82} In this case, it is possible that patients are admitted to critical care at different phases of disease; moreover, these phases may be clinically relevant and affect response to treatment. pathophysiological delay will be estimated using the concept of illness trajectories (which also may have a biological correlate){Osuchowski:2006p2107}. This means that a patient who is slowly deteriorating is likely to have been ill for longer. In other words, their pathophysiological time zero will be earlier than another patient who is is rapidly deteriorating. This illness trajectory will be estimated by measuring the change in severity of illness between ward assessment and ICU admission. The effect of these illness trajectories, and therefore of the pathophysiological timing of ICU admission, will be evaluated with particular attention to severe sepsis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Inpatients assessed for critical care

Patients admitted to Critical Care Units participating in the ICNARC CMP programme who have been assessed at any time on a ward prior to ICU admission by a critical care decision maker (e.g. the CCOT or any member of the medical staff on duty for the unit)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* Paediatric patients (Age \< 18 years)
* Elective or planned admissions to critical care
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wellcome Trust

OTHER

Sponsor Role collaborator

London School of Hygiene and Tropical Medicine

OTHER

Sponsor Role collaborator

Intensive Care National Audit & Research Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Steve Harris

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Steve Harris, MRCP FRCA

Role: PRINCIPAL_INVESTIGATOR

ICNARC / LSHTM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University College Hospital London

London, London, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

https://www.icnarc.org/Our-Research/Studies/Spotlight/About

Intensive Care National Audit \& Research Centre

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SPOT-Light

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sepsis Metabolomics
NCT01649440 COMPLETED